News
Markups

Leader Rodgers Demands Floor Vote for Oversight on Biden’s Baby Formula Crisis

Sep 21, 2022
Markups
Health
Oversight & Investigations
Press Release

Energy and Commerce Democrats Agree He has Failed Parents and Babies 

BREAKING NEWS: For parents, President Biden and the Food and Drug Administration (FDA) must answer for empty baby and infant formula shelves. 

Republicans and Democrats on the Energy and Commerce Committee JUST favorably reported Congressman Tim Walberg’s (R-MI) H. Res. 1287, which requests certain documents from the administration related to its delayed and disastrous response to this supply crisis.  

Now, House Energy and Commerce Republican Leader Cathy McMorris Rodgers (R-WA) is demanding Speaker Nancy Pelosi (D-CA) bring this resolution to the floor. 

“Parents—who are already struggling to afford groceries, gas, and electricity bills—still can’t find the baby formula they need,” said Rodgers. “President Joe Biden owes them answers. For months, my Republican colleagues on the Energy and Commerce Committee have been calling for complete transparency from his administration on why it repeatedly failed to act with urgency to address supply shortages and empty shelves. Today, Democrats on the Committee agreed. Now, we are demanding Speaker Pelosi bring this resolution to the floor and require the administration to hand over documents for robust and proper oversight of this crisis. We should do everything we can to make sure the administration is held accountable so these failures never happen again.” 

NOTE: H. Res. 1287 was reported favorably by the Energy and Commerce Committee by a bipartisan vote of (54-0). This comes after Republicans repeatedly called for the Biden administration to be completely transparent to moms and dads struggling to find baby formula. In July, Leader Rodgers, Health Subcommittee Republican Leader Brett Guthrie (R-KY), and Oversight Subcommittee Republican Leader Morgan Griffith (R-VA) requested the FDA produce memos and reports sent to the White House about this crisis. To date, the FDA has not shared a complete response to these requests with the Committee despite promises to do so.

Screen Shot 2022-12-01 at 4.53.44 PM.png

The Latest
May 21, 2026
Press Release
Chairman Guthrie Delivers Opening Statement at Full Committee Markup of 16 Bills

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, delivered the following opening statement at today’s Full Committee Markup of 16 bills.

Chairman Guthrie’s opening statement as prepared for delivery:

“Good morning and thank you all for attending today’s markup of 16 bills, touching on issues across the Committee’s jurisdiction.

“Today’s markup includes the Recycling Infrastructure and Accessibility Act, sponsored by Congresswoman Miller-Meeks, which establishes a pilot program at EPA to help build out recycling infrastructure in areas that currently lack household recycling. The bill also includes provisions to improve the collection of data regarding recycling rates and help identify areas for improvement.

“We have also worked across the aisle on our title of the Surface Transportation Reauthorization, and I want to commend the Members and staff across the whole Committee for their hard work to get us to where we are.

“This package modernizes the automotive industry and ensures that NHTSA has the tools it needs to ensure motor vehicle safety.

“The package also includes important priorities for many of our members ranging from modernizing tire regulations to strengthening flammability standards for automobiles.

“But having a thriving, American-based automotive supply chain is also a core national security interest, which is why we included a bipartisan ban on Chinese vehicles in this bill. The Chinese Communist Party has made clear that their government will use every tool at their disposal to surveil, influence, and manipulate Americans for their own gain.

“Our bipartisan mission today is to support a vibrant automotive industry, enhance safety, and repel the threats coming from our adversaries in Beijing. This package makes progress on all three of those goals, and I’m proud we were able to work together on this.

“Further, today’s markup builds upon the Health Subcommittee’s work last week to advance ten bills that increase flexibility to patients and providers, strengthen FDA's oversight of our supply chains, and ensure vital public health programs continue to serve Americans.

“A handful of the bills before us at the Committee today—including the EARLY Act, the AADAPT (ADAPT) Act, and the Stem Cell Therapeutic and Research Reauthorization Act to name just a few—focus on reauthorizing critical public health programs supporting patients by meeting them where they’re at.

“Finally, we’ll also advance bills to modernize FDA’s review and enforcement authorities, and we will also support two important patient access bills—the Choices for Increased Mobility Act and the Health Care Efficiency Through Flexibility Act—which seek to reduce administrative burdens and increase flexibility for both patients and providers.

“I look forward to the productive discussion on these 16 bills and voting to report them to the Full House.”